Pfizer, Inc. (PFE)
37.6 -0.61%
01:57 pm EDT; Powered by Koyfin
Pros
Stock price low relative to the 52-week range
Company’s profitability is improving
Forward dividend yield higher than the industry and sector averages
Forward P/B ratio low relative to industry peers
Forward P/S ratio low relative to industry peers
Buy analyst rating
Average analyst stock price above current stock price
Cons
Revenue growth lower than the industry and sector averages
Pros
- PFE stock price ($39.21) is close to the 52-week low ($38.63). Perhaps now is a good time to buy? See PFE price chart.
- PFE profitability is improving. The YoY profit margin change was 26.89 percentage points. See PFE profitability chart.
- PFE forward dividend yield is 4.23%, higher than the industry (2.22%) and sector (0.21%) forward dividend yields. See PFE forward dividend chart.
- PFE Price/Book ratio is 2.28, which is low compared to its industry peers’ P/B ratios. See PFE forward Price/Book ratio chart.
- PFE Price/Sales ratio is 2.19, which is low compared to its industry peers’ P/S ratios. See PFE forward Price/Sales ratio chart.
- PFE average analyst rating is Buy. See PFE analyst rating chart.
- PFE average analyst price target ($55.88) is above its current price ($39.21). See PFE price target chart.
Cons
- PFE quarterly revenue growth was 1.90%, lower than the industry and sector average revenue growth (7.80% and 3.00%, respectively). See PFE revenue growth chart.